Axar.az
UP
29 May 2020


E-cigarette company warned over marketing practices

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

The U.S. Food and Drug Administration warned JUUL Labs over false marketing practices for its tobacco products, accusing the vaping company of modifying the risks especially when outreaching to the youth.

Axar.az reports citing AA that agency said it issued a warning letter to JUUL Labs Inc. ''for marketing unauthorized modified risk tobacco products by engaging in labeling, advertising, and/or other activities directed to consumers, including a presentation given to youth at a school''.

The FDA's investigation of JUUL is the latest in a series of actions it has taken as part of an effort to shed light on the illegal marketing practices of e-cigarette companies and other electronic nicotine delivery systems (ENDS).

The FDA has been under fire recently by parents and health NGOs over its negligence to investigate the recent respiratory illnesses and deaths associated with vaping especially among the youth.

The agency had to launch a wide-ranging investigation after the vaping-related illnesses claimed four lives in the U.S. last week and hundreds of others were reported sick.

As many as 450 people across 33 U.S. states were hospitalized with lung illnesses related to the use of the electronic devices, health officials announced.

Date
2019.09.12 / 18:52
Author
Axar.az
Comments
See also

Confirmed worldwide Covid-19 death toll passes 347K

WHO warns of 'second peak' in areas where COVID-19 declining

Number of coronavirus cases in Finland rises to 6,599

Azerbaijan discloses number of coronavirus tests

Children and older adults to take part in vaccine trial

Africa's coronavirus infections near 104,000

Over 2 million have recovered from coronavirus - Study

WHO Baku Representative talked about the vaccine tests

Britain launches global tests for coronavirus

Record number of new coronavirus cases reported globally

Latest
 
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla